Patents Assigned to TRIO MEDICINES LTD
  • Benzodiazepine derivatives as CCK2/gastrin receptor antagonists
    Patent number: 10906884
    Abstract: The invention relates to benzodiazepine derivatives of formula (A) useful as CCK2/gastrin receptor antagonists, their preparation and their use in the treatment or prevention of disorders associated with CCK2/gastrin receptors, disorders caused by or associated with hypergastrinaemia, and gastric acid-related disorders.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: February 2, 2021
    Assignee: TRIO MEDICINES LTD
    Inventors: Malcolm James Boyce, Liv Thomsen, Donald Alan Gilbert, David Wood
  • Benzodiazepine derivatives as CCK2/gastrin receptor antagonists
    Patent number: 10308627
    Abstract: The invention relates to benzodiazepine derivatives of formula (A) useful as CCK2/gastrin receptor antagonists, their preparation and their use in the treatment or prevention of disorders associated with CCK2/gastrin receptors, disorders caused by or associated with hypergastrinaemia, and gastric acid-related disorders.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: June 4, 2019
    Assignee: TRIO MEDICINES LTD
    Inventors: Malcolm James Boyce, Liv Thomsen, Donald Alan Gilbert, David Wood